180 related articles for article (PubMed ID: 21851336)
21. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
[TBL] [Abstract][Full Text] [Related]
22. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
Young PW; Buckle DR; Cantello BC; Chapman H; Clapham JC; Coyle PJ; Haigh D; Hindley RM; Holder JC; Kallender H; Latter AJ; Lawrie KW; Mossakowska D; Murphy GJ; Roxbee Cox L; Smith SA
J Pharmacol Exp Ther; 1998 Feb; 284(2):751-9. PubMed ID: 9454824
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment with FK506 up-regulates insulin receptors in regenerating rat liver.
Escribano O; Fernández-Moreno MD; Piña MJ; Fueyo J; Menor C; Román ID; Guijarro LG
Hepatology; 2002 Sep; 36(3):555-61. PubMed ID: 12198647
[TBL] [Abstract][Full Text] [Related]
24. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes--role of insulin and IGF-I receptors.
Bäck K; Brännmark C; Strålfors P; Arnqvist HJ
Mol Cell Endocrinol; 2011 Jun; 339(1-2):130-5. PubMed ID: 21524684
[TBL] [Abstract][Full Text] [Related]
26. Changes of insulin binding in rat tissues after exposure to stress.
Macho L; Ficková M; Zórad S; Kvetnanský R
Physiol Res; 1999; 48(1):51-8. PubMed ID: 10470866
[TBL] [Abstract][Full Text] [Related]
27. Acute Treatment With XMetA Activates Hepatic Insulin Receptors and Lowers Blood Glucose in Normal Mice.
Bedinger DH; Kieffer DA; Goldfine ID; Roell MK; Adams SH
J Cell Biochem; 2015 Sep; 116(9):2109-19. PubMed ID: 25808283
[TBL] [Abstract][Full Text] [Related]
28. Engineering of insulin receptor isoform-selective insulin analogues.
Glendorf T; Stidsen CE; Norrman M; Nishimura E; Sørensen AR; Kjeldsen T
PLoS One; 2011; 6(5):e20288. PubMed ID: 21625452
[TBL] [Abstract][Full Text] [Related]
29. Prevalent role of the insulin receptor isoform A in the regulation of hepatic glycogen metabolism in hepatocytes and in mice.
Diaz-Castroverde S; Baos S; Luque M; Di Scala M; González-Aseguinolaza G; Gómez-Hernández A; Beneit N; Escribano O; Benito M
Diabetologia; 2016 Dec; 59(12):2702-2710. PubMed ID: 27600278
[TBL] [Abstract][Full Text] [Related]
30. Effect of hypothermia on insulin-receptor interaction in different rat tissues.
Torlinska T; Perz M; Madry E; Hryniewiecki T; Nowak KW; Mackowiak P
Physiol Res; 2002; 51(3):261-6. PubMed ID: 12234118
[TBL] [Abstract][Full Text] [Related]
31. Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms.
Knudsen L; De Meyts P; Kiselyov VV
Biochem J; 2011 Dec; 440(3):397-403. PubMed ID: 21838706
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of insulin binding by human and rat hepatocytes in primary culture: the possible role of insulin internalization and degradation.
Kalant N; Ozaki S; Maekubo H; Mitmaker B; Cohen-Khallas M
Endocrinology; 1984 Jan; 114(1):37-43. PubMed ID: 6360664
[TBL] [Abstract][Full Text] [Related]
33. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific expression of insulin receptor isoforms in obesity/type 2 diabetes mouse models.
Moruzzi N; Lazzeri-Barcelo F; Valladolid-Acebes I; Moede T; Paschen M; Leibiger B; Berggren PO; Leibiger IB
J Cell Mol Med; 2021 May; 25(10):4800-4813. PubMed ID: 33742502
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of selective insulin resistance in isolated hepatocytes.
Cook JR; Langlet F; Kido Y; Accili D
J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396
[TBL] [Abstract][Full Text] [Related]
36. Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody.
Hinke SA; Cieniewicz AM; Kirchner T; D'Aquino K; Nanjunda R; Aligo J; Perkinson R; Cooper P; Boayke K; Chiu ML; Jarantow S; Lacy ER; Liang Y; Johnson DL; Whaley JM; Lingham RB; Kihm AJ
Mol Metab; 2018 Apr; 10():87-99. PubMed ID: 29453154
[TBL] [Abstract][Full Text] [Related]
37. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.
Bevan AP; Burgess JW; Yale JF; Drake PG; Lachance D; Baquiran G; Shaver A; Posner BI
Am J Physiol; 1995 Jan; 268(1 Pt 1):E60-6. PubMed ID: 7840184
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral antidiabetic drugs on glycogen concentration and on glycogenolysis in different rat tissues.
Kammerer L; Steingaszner O; Lévay J; Dénes R
Rev Roum Med Intern; 1974; 11(1):145-7. PubMed ID: 4407682
[No Abstract] [Full Text] [Related]
39.
Wronkowitz N; Hartmann T; Görgens SW; Dietze-Schroeder D; Indrakusuma I; Choi IY; Park SH; Lee YM; Kwon SC; Kang Y; Hompesch M; Eckel J
Diabetes Obes Metab; 2017 Dec; 19(12):1722-1731. PubMed ID: 28497570
[TBL] [Abstract][Full Text] [Related]
40. Scintigraphic studies in rats. Kinetics of insulin analogues covering wide range of receptor affinities.
Jensen I; Kruse V; Larsen UD
Diabetes; 1991 May; 40(5):628-32. PubMed ID: 2022307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
